1. FDA Notifications
- Subjects
United States. Food and Drug Administration -- Licensing, certification and accreditation ,United States. Food and Drug Administration -- Standards ,Anti-HIV agents -- Packaging ,Anti-HIV agents -- Licensing, certification and accreditation ,Antiviral agents -- Packaging ,Antiviral agents -- Licensing, certification and accreditation ,Health counseling -- Standards ,Salmeterol -- Dosage and administration ,Salmeterol -- Standards ,Sildenafil -- Packaging ,Sildenafil -- Licensing, certification and accreditation ,Health ,Advair Diskus (Medication) -- Licensing, certification and accreditation ,Advair Diskus (Medication) -- Packaging ,Kaletra (Medication) -- Licensing, certification and accreditation ,Kaletra (Medication) -- Packaging ,Revatio (Medication) -- Licensing, certification and accreditation ,Revatio (Medication) -- Packaging ,Serevent (Medication) -- Licensing, certification and accreditation ,Serevent (Medication) -- Packaging - Abstract
Kaletra revisions to packaging approved On Jan. 29, 2009, the Food and Drug Administration (FDA) approved revisions to the lopinavir/ritonavir (Kaletra.sup.[R]) package insert to include drug-drug interaction information for concurrent [...]
- Published
- 2010